BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8087793)

  • 1. Health care policies affecting the treatment of patients with cancer and cancer research.
    Mortenson LE
    Cancer; 1994 Oct; 74(7 Suppl):2204-7. PubMed ID: 8087793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reimbursement issues facing patients, providers, and payers.
    Antman K
    Cancer; 1993 Nov; 72(9 Suppl):2842-5. PubMed ID: 8402516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current issues in oncology reimbursement.
    Bailes JS
    Oncology (Williston Park); 1995 Nov; 9(11 Suppl):185-9. PubMed ID: 8608051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Influence of Health Insurance Policy on Radiation Oncology Physician SBRT/SABR Use Practices: A North American Survey.
    Guo J; Kim H; Kalchman I; Dan TD; Zhan T; Werner-Wasik M
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):524-529. PubMed ID: 29280445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Payment and coverage issues affecting medical oncology.
    Bailes JS
    Breast Cancer Res Treat; 1993; 25(2):119-26. PubMed ID: 8347844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncology in the era of managed care.
    Gerszten PC
    J Oncol Manag; 1998; 7(3):21-3. PubMed ID: 10181577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncology services for members of a national managed care company.
    Zarkowsky H
    Cancer; 1998 May; 82(10 Suppl):2039-42. PubMed ID: 9587104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs.
    Berry SR; Bell CM; Ubel PA; Evans WK; Nadler E; Strevel EL; Neumann PJ
    J Clin Oncol; 2010 Sep; 28(27):4149-53. PubMed ID: 20697077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prior authorization burden. The process is frustrating, time-consuming and costly.
    Bell H
    Minn Med; 2014; 97(11-12):18-25. PubMed ID: 25651648
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical trials: are they a good buy?
    Bennett CL; Adams JR; Knox KS; Kelahan AM; Silver SM; Bailes JS
    J Clin Oncol; 2001 Dec; 19(23):4330-9. PubMed ID: 11731516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reimbursement for cancer treatment: coverage of off-label drug indications.
    American Society of Clinical Oncology
    J Clin Oncol; 2006 Jul; 24(19):3206-8. PubMed ID: 16717290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reimbursement policies constrain the practice of oncology.
    Laetz T; Silberman G
    JAMA; 1991 Dec; 266(21):2996-9. PubMed ID: 1820471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report on financing the new model of family medicine.
    Spann SJ;
    Ann Fam Med; 2004 Dec; 2 Suppl 3(Suppl 3):S1-21. PubMed ID: 15654084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking cessation counseling: a practice management perspective.
    Pohlig C
    Chest; 2006 Oct; 130(4):1231-3. PubMed ID: 17035460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use and coverage of novel cancer agents in managed care.
    Bailes JS
    Semin Oncol; 1994 Dec; 21(6 Suppl 14):34-7. PubMed ID: 7992098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the cost of antidepressants across state Medicaid programs.
    Kelton CM; Rebelein RP; Heaton PC; Ferrand Y; Guo JJ
    J Ment Health Policy Econ; 2008 Mar; 11(1):33-47. PubMed ID: 18424875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. State payer mandates to cover care in US oncology trials: do science and ethics matter?
    Taylor PL
    J Natl Cancer Inst; 2010 Mar; 102(6):376-90. PubMed ID: 20197514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reimbursement issues in clinical oncology.
    Vogelzang NJ; Chabner BA; Periman P; Ohrt DK; McCann BC; Burns JM; Bayer R
    Semin Oncol; 1988 Dec; 15(6 Suppl 6):34-43. PubMed ID: 3061015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.